COVID-19 Updates
Feature
Epidemic of brain fog? Long COVID’s effects worry experts
“We need to be paying attention to this. What we’ve seen is really the tip of the iceberg.”
News from the FDA/CDC
Children and COVID: Downward trend reverses with small increase in new cases
September’s 4-week decline becomes October’s inflationary reaction.
Feature
Three COVID scenarios that could spell trouble for the fall
Experts predict different scenarios, some more dire than others.
Conference Coverage
MD and APP-only care benefit patients in the ED
INOVA emergency department developed a Provider-Only Patients (POP) protocol for patients who required minimal nursing care.
News from the FDA/CDC
Children and COVID: Weekly cases dropped by 57% in September
Parents’ acceptance of vaccine misinformation linked to reduced uptake in children.
Latest News
Supreme Court turns away challenge to U.S. vaccine rule for health workers
The federal healthcare worker rule requires vaccination for about 10.3 million workers at 76,000 healthcare facilities including hospitals and...
Feature
Breakthrough COVID studies lend support to use of new boosters in immunosuppressed patients
The findings of two studies underscore the importance of booster vaccine doses in those with immune-mediated inflammatory diseases who are taking...
From the Journals
COVID attacks DNA in heart, unlike flu, study says
The damage was similar to the way chronic diseases such as diabetes and cancer appear in the heart, he said, with heart tissue showing DNA damage...
Conference Coverage
Severe COVID-19–related outcomes found worse in men with RA
A retrospective study of patients with rheumatoid arthritis and COVID-19 showed that men had more baseline comorbidities and increased risk of...
Latest News
COVID pandemic associated with anorexia in Canadian youth
“There was so much disruption and [so many] restrictions to young peoples’ daily routines ... That led to heightened anxiety and depression and...
News from the FDA/CDC
Children and COVID: September slowdown continues
Moderna, Pfizer/BioNTech seek emergency authorizations for the latest bivalent boosters.